Ilyang to present positive preclinical results of new influenza antiviral drug

Ilyang Pharmaceutical Co. said Tuesday that it will announce positive data from preclinical study of its new influenza antiviral drug at the 31st Annual Meeting to be hosted by the American Society for Virology and held at the University of Wisconsin-Madison between July 21 and 25, 2012.

The preclinical trial showed that Ilyang’s new antiviral drug was safe, effective, and well tolerated for...